Our findings that Arnt activates the CDKN2B promoter and that knockdown of Arnt causes a decrease in the mRNA level of CDKN2B in U2OS cells are in line with recent findings in HCC [40]. The gene discussed is ARNT; the disease is hepatocellular carcinoma.